| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACADM
|
acyl-CoA dehydrogenase, C-4 to C-12 straight chain
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADM
|
adrenomedullin
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK2
|
adrenergic, beta, receptor kinase 2
|
|
AGA
|
aspartylglucosaminidase
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANXA1
|
annexin A1
|
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APCS
|
amyloid P component, serum
|
|
APOC2
|
apolipoprotein C-II
|
|
ARIH1
|
ariadne RBR E3 ubiquitin protein ligase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
C1QTNF3
|
C1q and tumor necrosis factor related protein 3
|
|
C1R
|
complement component 1, r subcomponent
|
|
C1S
|
complement component 1, s subcomponent
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CALM2
|
calmodulin 2 (phosphorylase kinase, delta)
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD209
|
CD209 molecule
|
|
CD28
|
CD28 molecule
|
|
CD34
|
CD34 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD68
|
CD68 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CFH
|
complement factor H
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CKMT1A
|
creatine kinase, mitochondrial 1A
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
|
CLEC4C
|
C-type lectin domain family 4, member C
|
|
CLU
|
clusterin
|
|
CMIP
|
c-Maf inducing protein
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTSS
|
cathepsin S
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP4V2
|
cytochrome P450, family 4, subfamily V, polypeptide 2
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFA1
|
defensin, alpha 1
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1
|
|
DNM1
|
dynamin 1
|
|
DNM2
|
dynamin 2
|
|
DNM3
|
dynamin 3
|
|
DTNA
|
dystrobrevin, alpha
|
|
E2F1
|
E2F transcription factor 1
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EP300
|
E1A binding protein p300
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAN1
|
FANCD2/FANCI-associated nuclease 1
|
|
FAS
|
Fas cell surface death receptor
|
|
FBN1
|
fibrillin 1
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGG
|
fibrinogen gamma chain
|
|
FLNA
|
filamin A, alpha
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FMOD
|
fibromodulin
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXC2
|
forkhead box C2
|
|
FOXG1
|
forkhead box G1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FUS
|
FUS RNA binding protein
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GPR39
|
G protein-coupled receptor 39
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTA2
|
glutathione S-transferase alpha 2
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX)
|
|
HBB
|
hemoglobin, beta
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC11
|
histone deacetylase 11
|
|
HES5
|
hes family bHLH transcription factor 5
|
|
HFE
|
hemochromatosis
|
|
HHIP
|
hedgehog interacting protein
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HP
|
haptoglobin
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HTN3
|
histatin 3
|
|
HTT
|
huntingtin
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL17A
|
interleukin 17A
|
|
IL19
|
interleukin 19
|
|
IL1B
|
interleukin 1, beta
|
|
IL20
|
interleukin 20
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL24
|
interleukin 24
|
|
IL27
|
interleukin 27
|
|
IL31
|
interleukin 31
|
|
IL33
|
interleukin 33
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
IPO4
|
importin 4
|
|
IPO7
|
importin 7
|
|
IRF4
|
interferon regulatory factor 4
|
|
ISG20
|
interferon stimulated exonuclease gene 20kDa
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
JAK2
|
Janus kinase 2
|
|
JMJD6
|
jumonji domain containing 6
|
|
JUN
|
jun proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIAA0319
|
KIAA0319
|
|
KLHDC8B
|
kelch domain containing 8B
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
LAMA2
|
laminin, alpha 2
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LMNA
|
lamin A/C
|
|
LTA
|
lymphotoxin alpha
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBP
|
myelin basic protein
|
|
MCM3
|
minichromosome maintenance complex component 3
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEFV
|
Mediterranean fever
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MESP2
|
mesoderm posterior basic helix-loop-helix transcription factor 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGP
|
matrix Gla protein
|
|
MIR410
|
microRNA 410
|
|
MIR9-1
|
microRNA 9-1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOS
|
v-mos Moloney murine sarcoma viral oncogene homolog
|
|
MPZ
|
myelin protein zero
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NLRP12
|
NLR family, pyrin domain containing 12
|
|
NOTCH3
|
notch 3
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAH
|
phenylalanine hydroxylase
|
|
PANX1
|
pannexin 1
|
|
PAQR5
|
progestin and adipoQ receptor family member V
|
|
PAQR7
|
progestin and adipoQ receptor family member VII
|
|
PAQR8
|
progestin and adipoQ receptor family member VIII
|
|
PARP3
|
poly (ADP-ribose) polymerase family, member 3
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PHF6
|
PHD finger protein 6
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP1
|
plakophilin 1
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLD3
|
phospholipase D family, member 3
|
|
PLEKHO1
|
pleckstrin homology domain containing, family O member 1
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PNLIP
|
pancreatic lipase
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTX3
|
pentraxin 3, long
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RANBP2
|
RAN binding protein 2
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RET
|
ret proto-oncogene
|
|
RGS16
|
regulator of G-protein signaling 16
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RPS19
|
ribosomal protein S19
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCNN1D
|
sodium channel, non voltage gated 1 delta subunit
|
|
SEPN1
|
selenoprotein N, 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SHH
|
sonic hedgehog
|
|
SIL1
|
SIL1 nucleotide exchange factor
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SMAD3
|
SMAD family member 3
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SP1
|
Sp1 transcription factor
|
|
SPAST
|
spastin
|
|
SPD3
|
Synpolydactyly 3
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRGN
|
serglycin
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
SUSD4
|
sushi domain containing 4
|
|
SV2A
|
synaptic vesicle glycoprotein 2A
|
|
SV2B
|
synaptic vesicle glycoprotein 2B
|
|
SV2C
|
synaptic vesicle glycoprotein 2C
|
|
SYK
|
spleen tyrosine kinase
|
|
TAS1R2
|
taste receptor, type 1, member 2
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TCF4
|
transcription factor 4
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFR2
|
transferrin receptor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TJP1
|
tight junction protein 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNAP
|
TRAFs and NIK-associated protein
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRE17
|
TRE17 protein
|
|
TREML1
|
triggering receptor expressed on myeloid cells-like 1
|
|
TRIM41
|
tripartite motif containing 41
|
|
TTR
|
transthyretin
|
|
TUBA1A
|
tubulin, alpha 1a
|
|
TUBB2A
|
tubulin, beta 2A class IIa
|
|
TXN
|
thioredoxin
|
|
UBQLN1
|
ubiquilin 1
|
|
UBXN4
|
UBX domain protein 4
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VWF
|
von Willebrand factor
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
YBX1
|
Y box binding protein 1
|
